[{"id":"78718693-d2a7-49a3-80d4-5d35f5e25698","acronym":"CAR-LAM","url":"https://clinicaltrials.gov/study/NCT04169022","created_at":"2022-04-12T22:54:13.267Z","updated_at":"2024-07-02T16:35:19.872Z","phase":"","brief_title":"AML Cell Immunotherapy Using Chimeric Antigen Receptor T-cells","source_id_and_acronym":"NCT04169022 - CAR-LAM","lead_sponsor":"Centre Hospitalier Universitaire de Besancon","biomarkers":" IL1RAP","pipe":"","alterations":" ","tags":["IL1RAP"],"overall_status":"Completed","enrollment":" Enrollment 86","initiation":"Initiation: 07/10/2019","start_date":" 07/10/2019","primary_txt":" Primary completion: 10/02/2023","primary_completion_date":" 10/02/2023","study_txt":" Completion: 10/02/2023","study_completion_date":" 10/02/2023","last_update_posted":"2024-02-12"},{"id":"2fc3ba8a-fcdf-4262-9868-e700f0f5e0a6","acronym":"CAR-LMC","url":"https://clinicaltrials.gov/study/NCT02842320","created_at":"2022-04-12T22:52:39.309Z","updated_at":"2024-07-02T16:36:09.566Z","phase":"","brief_title":"Targeting Leukemic Stem Cell Expressing the IL-1RAP Protein in Chronic Myelogenous Leukemia (CML)","source_id_and_acronym":"NCT02842320 - CAR-LMC","lead_sponsor":"Centre Hospitalier Universitaire de Besancon","biomarkers":" IL1RAP","pipe":"","alterations":" ","tags":["IL1RAP"],"overall_status":"Completed","enrollment":" Enrollment 53","initiation":"Initiation: 10/14/2015","start_date":" 10/14/2015","primary_txt":" Primary completion: 07/15/2020","primary_completion_date":" 07/15/2020","study_txt":" Completion: 07/15/2020","study_completion_date":" 07/15/2020","last_update_posted":"2022-06-01"}]